Treatment of severe meconium aspiration syndrome with porcine surfactant

被引:66
作者
Halliday, HL
Speer, CP
Robertson, B
机构
[1] QUEENS UNIV BELFAST, DEPT CHILD HLTH, BELFAST BT7 1NN, ANTRIM, NORTH IRELAND
[2] UNIV TUBINGEN, CHILDRENS HOSP, DEPT NEONATOL, TUBINGEN, GERMANY
[3] KAROLINSKA INST, DEPT WOMEN & CHILD HLTH, DIV EXPT PERINATAL PATHOL, STOCKHOLM, SWEDEN
关键词
newborn; meconium aspiration syndrome; surfactant;
D O I
10.1007/s004310050532
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
This study is based on clinical data from a retrospective series of 54 infants with meconium aspiration syndrome treated with porcine surfactant at a median age of 14 h (range 1-176 h). Median arterial/alveolar oxygen tension ratio (a/A PO2 ratio) before treatment was 0.08 (range 0.02-0.23) and oxygenation index 25 (range 6-110). After treatment with surfactant at an initial dose of 50-200 mg/kg there was a modest but statistically significant increase in a/APO(2) ratio associated with a reduction of oxygenation index. Ten (18%) babies showed a 3-4 fold increase in a/APO(2) ratio within 1-2 h of treatment. Twenty-four (44%) babies showed little or no response by 1-2 h with the remaining infants showing modest improvement in oxygenation. One third of babies quired repeated doses of surfactant. Twenty-eight day survival was 81%, with two babies requiring extracorporeal membrane oxygenation. Conclusion Natural surfactant treatment of severe meconium aspiration may prove to be a useful intervention and randomised controlled :trolled clinical trials should be undertaken.
引用
收藏
页码:1047 / 1051
页数:5
相关论文
共 20 条
[1]  
AUTEN RL, 1991, PEDIATRICS, V87, P101
[2]   PATHOPHYSIOLOGY OF CONGENITAL DIAPHRAGMATIC HERNIA-III - EXOGENOUS SURFACTANT THERAPY FOR THE HIGH-RISK NEONATE WITH CDH [J].
GLICK, PL ;
LEACH, CL ;
BESNER, GE ;
EGAN, EA ;
MORIN, FC ;
MALANOWSKAKANTOCH, A ;
ROBINSON, LK ;
BRODY, A ;
LELE, AS ;
MCDONNELL, M ;
HOLM, B ;
RODGERS, BT ;
MSALL, ME ;
COUREY, NG ;
KARP, MP ;
ALLEN, JE ;
JEWETT, TC ;
COONEY, DR .
JOURNAL OF PEDIATRIC SURGERY, 1992, 27 (07) :866-869
[3]   ACUTE EFFECTS OF INSTILLATION OF SURFACTANT IN SEVERE RESPIRATORY-DISTRESS SYNDROME [J].
HALLIDAY, HL ;
MCCORD, FB ;
MCCLURE, BG ;
MCCREID, M .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1989, 64 (01) :13-16
[4]  
HOFKOSH D, 1991, PEDIATRICS, V87, P549
[5]  
JOBE AH, 1993, NEW ENGL J MED, V328, P861
[6]  
KHAMMASH H, 1993, PEDIATRICS, V92, P135
[7]   IMPROVED PULMONARY OUTCOME AFTER EXOGENOUS SURFACTANT THERAPY FOR RESPIRATORY-FAILURE IN TERM INFANTS REQUIRING EXTRACORPOREAL MEMBRANE-OXYGENATION [J].
LOTZE, A ;
KNIGHT, GR ;
MARTIN, GR ;
BULAS, DI ;
HULL, WM ;
ODONNELL, RM ;
WHITSETT, JA ;
SHORT, BL .
JOURNAL OF PEDIATRICS, 1993, 122 (02) :261-268
[8]   INHIBITION OF PULMONARY SURFACTANT FUNCTION BY MECONIUM [J].
MOSES, D ;
HOLM, BA ;
SPITALE, P ;
LIU, MY ;
ENHORNING, G .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (02) :477-481
[9]  
Ohama Yoichi, 1994, Acta Paediatrica Japonica, V36, P236
[10]  
PANDIT PB, 1995, PEDIATRICS, V95, P851